[go: up one dir, main page]

ES8500997A1 - Un metodo para producir un peptido. - Google Patents

Un metodo para producir un peptido.

Info

Publication number
ES8500997A1
ES8500997A1 ES520997A ES520997A ES8500997A1 ES 8500997 A1 ES8500997 A1 ES 8500997A1 ES 520997 A ES520997 A ES 520997A ES 520997 A ES520997 A ES 520997A ES 8500997 A1 ES8500997 A1 ES 8500997A1
Authority
ES
Spain
Prior art keywords
specificity
viral antigens
foot
small peptides
mouth disease
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES520997A
Other languages
English (en)
Other versions
ES520997A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biogen NV
Original Assignee
Biogen NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biogen NV filed Critical Biogen NV
Publication of ES8500997A1 publication Critical patent/ES8500997A1/es
Publication of ES520997A0 publication Critical patent/ES520997A0/es
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32111—Aphthovirus, e.g. footandmouth disease virus
    • C12N2770/32122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32111—Aphthovirus, e.g. footandmouth disease virus
    • C12N2770/32134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/806—Antigenic peptides or proteins
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/22—Viral peptide or viral protein
    • Y10S930/222—Foot and mouth disease related

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

METODO PARA PRODUCIR UN PEPTIDO QUE EXHIBE LA ANTIGENICIDAD DE UN ANTIGENO VIRAL DE LA FIEBRE AFTOSA.CONSISTE EN CULTIVAR, BAJO CONDICIONES DE FERMENTACION CONVENCIONALES, UN ORGANISMO HOSPEDANTE TRANSFORMADO MEDIANTE UNA MOLECULA DE ADN RECOMBINANTE PRODUCIDA INTRODUCIENDO EN UN VEHICULO DE CLONACION UNA SECUENCIA DE ADN QUE CODIFICA DICHO POLIPEPTIDO. EL PEPTIDO OBTENIDO SE AISLA DEL CULTIVO MEDIANTE LA SEPARACION DE LAS CELULAS HOSPEDANTES Y A CONTINUACION SE PURIFICA.
ES520997A 1982-03-26 1983-03-25 Un metodo para producir un peptido. Granted ES520997A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8209041 1982-03-26

Publications (2)

Publication Number Publication Date
ES8500997A1 true ES8500997A1 (es) 1984-11-01
ES520997A0 ES520997A0 (es) 1984-11-01

Family

ID=10529329

Family Applications (1)

Application Number Title Priority Date Filing Date
ES520997A Granted ES520997A0 (es) 1982-03-26 1983-03-25 Un metodo para producir un peptido.

Country Status (10)

Country Link
US (1) US4605512A (es)
EP (1) EP0090581A3 (es)
JP (1) JPS58213723A (es)
AU (1) AU1255383A (es)
DK (1) DK139083A (es)
ES (1) ES520997A0 (es)
IL (1) IL68201A0 (es)
NO (1) NO831098L (es)
PT (1) PT76451B (es)
ZA (1) ZA831854B (es)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1983003547A1 (en) * 1982-04-14 1983-10-27 Bittle, James, L. Synthetic picornavirus antigen
US5230888A (en) * 1982-05-06 1993-07-27 Massachusetts Institute Of Technology Production of neutralizing antibodies by polypeptide VP1 of enteroviruses and by oligopeptide fragments of polypeptide VP1
GB2128621B (en) * 1982-10-11 1987-08-12 Nat Biolog Standards Board Polypeptides useful in vaccination against enteroviruses
GB8301928D0 (en) * 1983-01-24 1983-02-23 Nicholson B H Process for producing polypeptides
CA1247080A (en) * 1983-03-08 1988-12-20 Commonwealth Serum Laboratories Commission Antigenically active amino acid sequences
AU573574B2 (en) * 1983-03-08 1988-06-16 Chiron Mimotopes Pty Ltd Immunogenic deteminants of foot and mouth disease virus
NZ207394A (en) * 1983-03-08 1987-03-06 Commw Serum Lab Commission Detecting or determining sequence of amino acids
WO1984003506A1 (en) * 1983-03-08 1984-09-13 Commw Serum Lab Commission Antigenically active amino acid sequences
AU576750B2 (en) * 1983-03-08 1988-09-08 Chiron Mimotopes Pty Ltd Method of determining antigenically active amino acid sequences
US4894332A (en) * 1985-03-27 1990-01-16 Biogen, Inc. DNA sequences coding for Mycoplasma hypopneumoniae surface antigens, methods of use to make the corresponding proteins
US4732971A (en) * 1985-06-03 1988-03-22 Eli Lilly And Company Synthetic vaccines for foot and mouth disease
US6074650A (en) * 1985-06-24 2000-06-13 Hoechst Aktiengesellschaft Membrane anchor/active compound conjugate, its preparation and its uses
US6024964A (en) * 1985-06-24 2000-02-15 Hoechst Aktiengesellschaft Membrane anchor/active compound conjugate, its preparation and its uses
DE3813821A1 (de) * 1988-04-22 1989-11-02 Hoechst Ag Synthetische vakzine gegen die maul- und klauenseuche und verfahren zu deren herstellung
EP0394326B1 (en) * 1987-12-10 1996-07-31 La Jolla Cancer Research Foundation Methods for the production of conformationally stabilized cell adhesion peptides
US5827821A (en) 1987-12-10 1998-10-27 The Burnham Institute Conformationally stabilized cell adhesion peptides
US5864008A (en) * 1988-03-25 1999-01-26 James; Stephen Peptides derived from foot-and-mouth disease virus, pharmaceutical compositions, and methods for using the peptides
JPH03504975A (ja) * 1988-06-14 1991-10-31 セル―エスシーアイ　コーポレイション 異種官能性細胞免疫剤、それを含有するワクチン及びその使用方法
US5648330A (en) * 1990-04-06 1997-07-15 La Jolla Cancer Research Foundation Method and composition for treating vascular graft occlusion
US6521594B1 (en) 1990-04-06 2003-02-18 La Jolla Cancer Research Foundation Method and composition for treating thrombosis
AU660926B2 (en) * 1990-04-06 1995-07-13 La Jolla Cancer Research Foundation Method and composition for treating thrombosis
US5780303A (en) * 1990-04-06 1998-07-14 La Jolla Cancer Research Foundation Method and composition for treating thrombosis
US5612311A (en) 1990-04-06 1997-03-18 La Jolla Cancer Research Foundation Method and composition for treating thrombosis
US5672585A (en) * 1990-04-06 1997-09-30 La Jolla Cancer Research Foundation Method and composition for treating thrombosis
DE19638044A1 (de) * 1996-09-18 1998-03-19 Bayer Ag Immunogene Peptide von Maul- und Klauenseuchen-Viren
CN105175516B (zh) * 2009-06-04 2018-11-27 中牧实业股份有限公司 一种动物用肽疫苗及其制备

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT73021B (en) * 1980-05-12 1983-10-19 Biogen Nv Process for producing dna sequences of recombinant dna molecules and polipeptides with specificyty on foot mouth disease as viral antigens
DE3177298T2 (de) * 1980-06-06 1993-07-01 Biogen Inc Verbesserte vektoren, verfahren zur herstellung solcher vektoren und zur expression von klonierten genen.
FI83662C (fi) * 1980-07-17 1991-08-12 Scripps Clinic Res Diagnostik antikropp och foerfarande foer dess framstaellning.
SE8105516L (sv) * 1980-09-18 1982-03-19 Wellcome Found Syntetisk dna och forfarande for framstellning derav
ES8306797A1 (es) * 1981-04-29 1983-06-01 Biogen Nv Un metodo para producir un polipeptido.
WO1983003547A1 (en) * 1982-04-14 1983-10-27 Bittle, James, L. Synthetic picornavirus antigen
EP0105481A1 (en) * 1982-09-30 1984-04-18 The Wellcome Foundation Limited Novel antigens and vaccines containing them

Also Published As

Publication number Publication date
PT76451A (en) 1983-04-01
US4605512A (en) 1986-08-12
DK139083A (da) 1983-09-27
IL68201A0 (en) 1983-06-15
ZA831854B (en) 1984-01-25
AU1255383A (en) 1983-09-29
PT76451B (en) 1986-03-11
NO831098L (no) 1983-09-27
EP0090581A2 (en) 1983-10-05
EP0090581A3 (en) 1984-10-24
ES520997A0 (es) 1984-11-01
DK139083D0 (da) 1983-03-25
JPS58213723A (ja) 1983-12-12

Similar Documents

Publication Publication Date Title
ES8500997A1 (es) Un metodo para producir un peptido.
MY103182A (en) Vaccines against acquired immune deficiency syndrome.
EP0608261A4 (en) COMPOSITION OF AN IMMUNREACTIVE HEPATITIS C VIRUS POLYPEPTIDE.
KR0176265B1 (en) Causative agent of the mystery swine disease, and vaccine compositions
ES8801318A1 (es) Un procedimiento para la produccion de un peptido.
ES2156199T3 (es) Polipeptido inductor de la produccion de interferon-gamma, anticuerpos monoclonales y composicion para el tratamiento o la prevencion de enfermedades sensibles al interferon-gamma.
IL138424A (en) Covalently reactive antigen analogs and pharmaceutical compositions containing the same
ATE496630T1 (de) Immunologische zusammensetzung und impfstoffe, die einen auf n-formyl-methionyl peptide bestehenden adjuvans enthalten
IL89701A0 (en) Recombinant retroviruses,method for the production thereof and pharmaceutical composition containing the same
ATE47524T1 (de) Hundeparvovirus-impfstoffe.
DE69131014D1 (de) Rekombinante avirulente salmonella antifruchtbarkeitsimpfstoffe
DK0588578T3 (da) Immunogener
BR9810907A (pt) Anticorpos monoclonais e policlonais, peptìdeo suscetìvel de gerar um anticorpo, agente imunogênico, sequência de nucleotìdeos, composição farmacêutica, uso de pelo menos um anticorpo, kit de diagnóstico, e, processo para preparar um agente imunogênico
ES2164914T3 (es) Medicamentos de inmunoterapia que contienen anticuerpos que detectan especificamente el antigeno mhcii del paciente a tratar.
NO996514L (no) Overflateantigener og proteiner nyttige i sammensetninger for diagnose og forebygging av Lymesykdom
FR2676068B1 (fr) Souches recombinantes immunogenes de b. anthracis - compositions immunogenes les contenant.
ATE154244T1 (de) Induzierung eines schutzes gegen virale infektionen
BR9612422A (pt) Pseudo-partìculas virais recombinantes, composição, utilização de pseudo-partìculas, e, processo de estimulação in vitro de respostas t citotóxicas de linfócitos provenientes de indivìduos atingidos por infecções virais ou tumorais.
FR2650954B1 (fr) Composition resultant de la reunion d'un epitope b de la glycoproteine d'enveloppe d'un retrovirus du type iv et d'un epitope t issu d'une proteine distincte codee par ce retrovirus et leur application a la production d'anticorps protecteurs contre le sida
FI950883A0 (fi) BAPP-C100-reseptorin kloonaus ja ilmentäminen
FR2646607B1 (fr) Anticorps monoclonaux anti-b2 microglobuline